BABA Up, PGEN Down: Upside, Downside Movers in the Morning

Avatar photo Doug Kass on November 2, 2026

– $INO +262% (FDA grants accelerated approval to VOCERYQ to reduce surgery frequency in adults with recurrent respiratory papillomatosis)

– $PERI +31% (agrees to be acquired by Affle for $11.70 a share in cash, valuing the deal at about $420M)

– $IDXX +7.8% (Q3 beat and FY revenue and EPS outlooks were raised, outweighing a slightly lower margin range)

– $BABA +3.3% (China adds liquidity through a 100B-yuan swap facility, while reports point to BABA support for AAPL’s China AI rollout)

– $SKHY +3.2%, MU +1.1%, WDC +1.0%, SMTC +1.3% (memory and connectivity names rebound from Friday’s chip rout as Deutsche Bank turns bullish on US technology)

– $GFI +3.1%, AG +1.7%, HL +1.9% (gold and silver miners rebound as precious-metal prices recover)

– $RIVN +3.0% (UBS upgrades to Buy on valuation after the recent selloff)

– $CRWD +2.6% (Deutsche Bank upgrades to Buy)

– $EL +2.3% (Q1 beat with strong margin expansion and the FY sales, margin and EPS outlook raised)

– $AU +2.2% (TD Cowen initiates at Buy as gold rebounds)

– $FORM +1.7% (Freedom Capital upgrades to Buy after record Q3 results and the recent pullback)

– $CRWV +1.4%, BE +1.2%, $VRT +1.3% (AI-infrastructure names rebound with technology after the sharp three-week selloff)

Downside

– $KPTI -69% (files Chapter 11 and names Ayrmid as lead bidder in a court-supervised sale process)

– $PGEN -28% (falls on new RRP competition after the FDA approves INO’s VOCERYQ)

– $KOS -9.2% (Q3 profit and revenue missed expectations as crude prices retreat)

– $CHKP -6.3% (Q3 revenue slipped and missed expectations as management said the recovery is taking longer than anticipated)

– $EQNR -2.9%, $OXY -2.0%, $APA -1.9%, $XOM -1.3%, $CVX -1.1% (oil producers fall as crude drops nearly 4% on renewed US-Iran diplomacy)

Upside, Downside Movers in the Morning

Avatar photo Doug Kass on October 20, 2026

Upside

– $RAPP +26% (Phase 2 RAP-219 trial met the primary and secondary endpoints in bipolar mania)

– $MSCI +5.9% (Q3 earnings and revenue topped expectations)

– $EFX +5.5% (sharply positive initial reaction to Q3 results released before the bell)

– $HTZ +5.0% (Oro Mobility secured an $80 million strategic equity investment to accelerate its standalone growth)

– $HAL +4.4% (Q3 earnings and revenue beat expectations)

– $SNY +2.4% (no clear fresh catalyst identified; unusually strong, liquid ADR move)

– $APA +1.9%, $XOM +1.2%, $CVX +1.4%, $COP +1.5%, $OXY +1.6%, $SLB +1.4% (energy names rise as crude jumps on renewed Middle East supply risks)

– $VICR +1.7% (Q3 product and royalty revenue surged and gross margin expanded sharply)

Downside

– $GM -7.6% (Q3 beat, but the full-year profit range was narrowed with the upper end cut, disappointing expectations for another guidance raise)

– $GPC -6.3% (quarter narrowly beat, but the full-year earnings range was narrowed and its upper end cut)

– $STLD -5.4% (Q3 profit missed consensus and fell below the company’s own guidance despite a revenue beat)

– $AAOI -4.6%, SKHY -4.8%, COHR -3.5%, SNDK -3.2%, MU -2.7%, LITE -2.7% (AI hardware, memory and optical names fall as renewed bubble concerns and a weak Korean AI listing pressure the trade)

– $CCK -4.3% (Q3 reaction turns negative as rising input costs offset strong beverage-can volume growth)

– $CRWV -3.9%, NBIS -4.4%, IREN -4.3% (debt-heavy AI-infrastructure names fall as borrowing-cost and funding concerns deepen)

– $GE -3.6% (Q3 beat and the outlook was raised, but shares slip in a high-expectations sell-the-news reaction)

– $BHP -3.0% (quarterly copper production fell 19% on lower grades, maintenance and operational disruptions)

– $AAPL -1.4% (Loop Capital downgrades to Hold from Buy and cuts its target on weaker iPhone shipment expectations)